Filter
News & Insights
- Startups & InnovatorsPartnering, Business Development & Licensing
Gilead’s $2.2bn buy of Ouro Medicines includes Galapagos alliance
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
‘Expect the unexpected’: Navigating biotech M&A in an unpredictable climate
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Spring has sprung: Laigo Bio closes $19.7m financing round for dual-target therapeutics
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
From quiet beginnings to global recognition: The BioNTech story
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Cellmabs and Valvian founder Nuno Prego Ramos to speak at the opening of BIO-Europe Spring 2026
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
BIO-Europe Spring Strengthens Collaboration with YVC Collective to Support Emerging Biotech Innovators
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Innovation Statement – a call to global biotechnology action
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Biotech Showcase™ 2026 Brought Early-Stage Biotech Innovation to the Forefront During JPM Healthcare Week
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
BIO-Europe® Innovation Statement
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Sanofi acquires Dynavax for $2.2bn, adding Hepatitis B vax and shingles candidate
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Zejing’s DLL3 cancer drug goes global with AbbVie co-sign
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Merck reportedly in talks to buy Revolution in huge $28–32bn deal
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Rumor has it: Sanofi eyes higher bid for retinal drug developer
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Double take: Novartis signs back-to-back licensing agreements
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Eikon Therapeutics sets sights on public markets
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Parabilis Medicines’ latest financing round causes IPO whispers
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Medline targets $5.37bn in landmark IPO
Read More - Investment in Biotech, MedTech & Digital HealthStartups & InnovatorsPartnering, Business Development & Licensing
Aktis Oncology sets sights on first IPO of 2026
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
Lisbon: Charting the New Course for European Life Sciences
Read More - Startups & InnovatorsPartnering, Business Development & Licensing
The integration advantage: How Novartis unified its deal-making operations
Read More